Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2017 1
2018 4
2019 7
2020 3
2021 6
2022 7
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Reply by Authors.
Antonelli A, Cindolo L, Sandri M, Annino F, Carini M, Celia A, D'Orta C, De Concilio B, Furlan M, Giommoni V, Ingrosso M, Mari A, Muto G, Nucciotti R, Porreca A, Primiceri G, Schips L, Sessa F, Simeone C, Veccia A, Minervini A; AGILE Group. Antonelli A, et al. J Urol. 2019 Jul;202(1):68. doi: 10.1097/01.JU.0000557722.09229.13. Epub 2019 Jun 7. J Urol. 2019. PMID: 30925109 No abstract available.
Adaptive Global Innovative Learning Environment for Glioblastoma: GBM AGILE.
Alexander BM, Ba S, Berger MS, Berry DA, Cavenee WK, Chang SM, Cloughesy TF, Jiang T, Khasraw M, Li W, Mittman R, Poste GH, Wen PY, Yung WKA, Barker AD; GBM AGILE Network. Alexander BM, et al. Clin Cancer Res. 2018 Feb 15;24(4):737-743. doi: 10.1158/1078-0432.CCR-17-0764. Epub 2017 Aug 16. Clin Cancer Res. 2018. PMID: 28814435 Review.
Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial.
Khoo SH, FitzGerald R, Saunders G, Middleton C, Ahmad S, Edwards CJ, Hadjiyiannakis D, Walker L, Lyon R, Shaw V, Mozgunov P, Periselneris J, Woods C, Bullock K, Hale C, Reynolds H, Downs N, Ewings S, Buadi A, Cameron D, Edwards T, Knox E, Donovan-Banfield I, Greenhalf W, Chiong J, Lavelle-Langham L, Jacobs M, Northey J, Painter W, Holman W, Lalloo DG, Tetlow M, Hiscox JA, Jaki T, Fletcher T, Griffiths G; AGILE CST-2 Study Group. Khoo SH, et al. Lancet Infect Dis. 2023 Feb;23(2):183-195. doi: 10.1016/S1473-3099(22)00644-2. Epub 2022 Oct 19. Lancet Infect Dis. 2023. PMID: 36272432 Free PMC article. Clinical Trial.
Itaconic acid production is regulated by LaeA in Aspergillus pseudoterreus.
Pomraning KR, Dai Z, Munoz N, Kim YM, Gao Y, Deng S, Lemmon T, Swita MS, Zucker JD, Kim J, Mondo SJ, Panisko E, Burnet MC, Webb-Robertson BM, Hofstad B, Baker SE, Burnum-Johnson KE, Magnuson JK; Agile BioFoundry. Pomraning KR, et al. Metab Eng Commun. 2022 Aug 24;15:e00203. doi: 10.1016/j.mec.2022.e00203. eCollection 2022 Dec. Metab Eng Commun. 2022. PMID: 36065328 Free PMC article.
AGILE: a seamless phase I/IIa platform for the rapid evaluation of candidates for COVID-19 treatment: an update to the structured summary of a study protocol for a randomised platform trial letter.
Griffiths GO, FitzGerald R, Jaki T, Corkhill A, Reynolds H, Ewings S, Condie S, Tilt E, Johnson L, Radford M, Simpson C, Saunders G, Yeats S, Mozgunov P, Tansley-Hancock O, Martin K, Downs N, Eberhart I, Martin JWB, Goncalves C, Song A, Fletcher T, Byrne K, Lalloo DG, Owen A, Jacobs M, Walker L, Lyon R, Woods C, Gibney J, Chiong J, Chandiwana N, Jacob S, Lamorde M, Orrell C, Pirmohamed M, Khoo S; AGILE investigators. Griffiths GO, et al. Trials. 2021 Jul 26;22(1):487. doi: 10.1186/s13063-021-05458-4. Trials. 2021. PMID: 34311777 Free PMC article.
An Open Label, Adaptive, Phase 1 Trial of High-Dose Oral Nitazoxanide in Healthy Volunteers: An Antiviral Candidate for SARS-CoV-2.
Walker LE, FitzGerald R, Saunders G, Lyon R, Fisher M, Martin K, Eberhart I, Woods C, Ewings S, Hale C, Rajoli RKR, Else L, Dilly-Penchala S, Amara A, Lalloo DG, Jacobs M, Pertinez H, Hatchard P, Waugh R, Lawrence M, Johnson L, Fines K, Reynolds H, Rowland T, Crook R, Okenyi E, Byrne K, Mozgunov P, Jaki T, Khoo S, Owen A, Griffiths G, Fletcher TE; AGILE platform. Walker LE, et al. Clin Pharmacol Ther. 2022 Mar;111(3):585-594. doi: 10.1002/cpt.2463. Epub 2021 Nov 13. Clin Pharmacol Ther. 2022. PMID: 34699618 Free PMC article. Clinical Trial.
Terrestrial gamma-ray flashes as powerful particle accelerators.
Tavani M, Marisaldi M, Labanti C, Fuschino F, Argan A, Trois A, Giommi P, Colafrancesco S, Pittori C, Palma F, Trifoglio M, Gianotti F, Bulgarelli A, Vittorini V, Verrecchia F, Salotti L, Barbiellini G, Caraveo P, Cattaneo PW, Chen A, Contessi T, Costa E, D'Ammando F, Del Monte E, De Paris G, Di Cocco G, Di Persio G, Donnarumma I, Evangelista Y, Feroci M, Ferrari A, Galli M, Giuliani A, Giusti M, Lapshov I, Lazzarotto F, Lipari P, Longo F, Mereghetti S, Morelli E, Moretti E, Morselli A, Pacciani L, Pellizzoni A, Perotti F, Piano G, Picozza P, Pilia M, Pucella G, Prest M, Rapisarda M, Rappoldi A, Rossi E, Rubini A, Sabatini S, Scalise E, Soffitta P, Striani E, Vallazza E, Vercellone S, Zambra A, Zanello D; AGILE Team. Tavani M, et al. Phys Rev Lett. 2011 Jan 7;106(1):018501. doi: 10.1103/PhysRevLett.106.018501. Epub 2011 Jan 3. Phys Rev Lett. 2011. PMID: 21231775
Is off-clamp robot-assisted partial nephrectomy beneficial for renal function? Data from the CLOCK trial.
Antonelli A, Cindolo L, Sandri M, Veccia A, Annino F, Bertagna F, Carini M, Celia A, D'Orta C, De Concilio B, Furlan M, Giommoni V, Ingrosso M, Mari A, Nucciotti R, Olianti C, Porreca A, Primiceri G, Schips L, Sessa F, Bove P, Simeone C, Minervini A; AGILE Group (Italian Group for Advanced Laparo-Endoscopic Surgery). Antonelli A, et al. BJU Int. 2022 Feb;129(2):217-224. doi: 10.1111/bju.15503. Epub 2021 Jul 4. BJU Int. 2022. PMID: 34086393 Clinical Trial.
24 results